For BenchSci's reagent selection tool, should we emphasize breadth of coverage across many reagent types or depth of information for key reagents like antibodies?

Introduction

The trade-off we're examining today is whether BenchSci's reagent selection tool should prioritize breadth of coverage across many reagent types or depth of information for key reagents like antibodies. This decision is crucial for BenchSci's product strategy and will significantly impact user experience, market positioning, and resource allocation. I'll analyze this trade-off by considering user needs, business objectives, and technical feasibility to provide a comprehensive recommendation.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm thinking BenchSci's current market position might influence this decision. Could you share how our tool currently compares to competitors in terms of reagent coverage and depth?

Why it matters: Helps understand our competitive advantage and gaps Expected answer: We lead in antibody depth but lag in breadth of other reagents Impact on approach: Would influence whether we need to defend our strength or address a weakness

• Business Context: Based on our revenue model, I assume we have partnerships with reagent suppliers. How do these partnerships factor into our product decisions?

Why it matters: Partnerships could influence our ability to expand breadth or depth Expected answer: Partnerships are crucial, with some exclusivity agreements Impact on approach: Would need to consider partner relationships in the strategy

• User Impact: I'm curious about our user segments. Can you tell me which segment is growing fastest and their specific needs?

Why it matters: Helps prioritize features based on user growth and retention Expected answer: Academic researchers are growing fast, needing broader coverage Impact on approach: Might lean towards breadth if this is a key growth segment

• Technical Feasibility: Considering our current architecture, how challenging would it be to significantly expand our coverage to new reagent types?

Why it matters: Determines the feasibility and timeline of expanding breadth Expected answer: Moderate challenge, requiring 3-6 months of development Impact on approach: Would influence the timeline and resource allocation for breadth expansion

• Resource Allocation: How flexible is our budget for this initiative? Are we looking at a fixed resource pool or is there room for expansion?

Why it matters: Helps understand if we can pursue both options or must choose Expected answer: Limited flexibility, likely need to prioritize one direction Impact on approach: Would push towards a more focused strategy rather than trying to do both